Clinical Trial Update: QL1706 Plus Chemotherapy as Neoadjuvant Therapy for Locally Advanced Cervical Cancer: A Phase II Trial [Phase 2]

View source ↗

Summary

Phase II trial evaluating QL1706 plus chemotherapy as neoadjuvant therapy for locally advanced cervical cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• QL1706

Snippet

Sponsor: Affiliated Cancer Hospital & Institute of Guangzhou Medical University | Conditions: Neoadjuvant Treatment for Locally Advanced Cervical Cancer | Phase 2 | Status: RECRUITING